Related Experiment Video
Updated: Jun 15, 2025
05:33
Author Spotlight: Alleviating Nausea and Vomiting in Pregnancy with Safe and Effective Auricular Acupuncture
Published on: August 4, 2023
1.3K
A call to action [plans] for cyclic vomiting syndrome
John M Rosen1, Patrick T Reeves2,3
1Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Children's Mercy Hospital, University of Missouri, Kansas, Missouri, USA.
Neurogastroenterology and Motility
|August 27, 2024
Summary
Cyclic vomiting syndrome (CVS) is a gut-brain interaction disorder. A new CVS Action Plan may improve home management and emergency care for patients with this chronic condition.
Area of Science:
- Gastroenterology
- Neurology
- Pediatrics
Background:
- Cyclic vomiting syndrome (CVS) is a complex gut-brain interaction disorder.
- It presents with a wide clinical spectrum in both children and adults.
- Clinical action plans are established tools for managing chronic conditions.
Purpose of the Study:
- To introduce the CVS Action Plan, a tool designed for managing CVS.
- To address the chronic and acute care needs of individuals with CVS.
- To facilitate treatment and improve outcomes for CVS patients.
Main Methods:
- Development of the CVS Action Plan.
- Review of anecdotal and indirect evidence supporting its use.
- Comparison to action plans for other functional gastrointestinal disorders.
Main Results:
- The CVS Action Plan has been developed to meet the needs of CVS patients.
- While not yet clinically tested for efficacy, supporting evidence exists.
- The plan aims to simplify home management and emergency care.
Conclusions:
- The CVS Action Plan offers potential benefits for managing cyclic vomiting syndrome.
- It may streamline disease recognition and acute care in emergency settings.
- Further research is needed to establish clinical efficacy.
Related Concept Videos
01:22Pathophysiology of Vomiting
347
Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
347
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
154
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
154
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
181
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
181
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
238
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
238
01:29Gastroesophageal Reflux Disease II: Clinical Features and Management
62
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
62
01:30Bulimia Nervosa
60
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
60